Atlas Trials

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Clinical trial NCT05351879 · COMPLETED

Trial details

NCT number
NCT05351879
Sponsor
Linkoeping University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2022-05-09
Primary completion
2023-08-29
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.